Lamictal, also known by its generic name lamotrigine, is an anticonvulsant epilepsy prescription used to treat epilepsy and bipolar disorder. Studies have suggested that there is a strong link between Lamictal use and birth defects, aseptic meningitis, suicidal thoughts and Stevens-Johnson Syndrome.
If you or a loved one has suffered from the harmful side effects of Lamictal, you may be eligible to pursue legal recourse.
Complete the Free Case Evaluation form on this page to schedule a no-obligation consultation with one of our dangerous drug lawyers to determine if you are able to file a Lamictal lawsuit.
Lamictal Birth Defects and The FDA
The FDA sent an alert to physicians in 2006, alerting them of risks associated with the drug upon reviewing data from the North American Anti-Epileptic Drug Pregnancy Registry (NAAED). The NAAED found a strong link between Lamictal use and birth defects.
Specifically, according to the NAAED Registry, women who used Lamictal during the first trimester were more likely to give birth to children with cleft palates and cleft lips than the general population.
In August 2010, the FDA released a Lamictal warning that informed the public that the use of Lamictal can cause aseptic meningitis, a form of meningitis that is not caused by bacterial infection. Some medications, like Lamictal, are often linked to the inflaming of the meninges, the membrane that protects the spinal cord and brain. Common symptoms of aseptic meningitis include:
- Abnormal sensitivity to light
- Stiff neck
Between the date of Lamictal’s approval in December 1994 and November 2009, the FDA identified 40 cases of aseptic meningitis. If you or a loved one has taken Lamictal and experienced any of these symptoms, it is important that you seek medical attention right away.
Suicidal Thoughts Linked to Lamictal
In January 2008, the FDA issued a drug safety alert regarding the potential of all anti-convulsant epilepsy drugs to cause patients to have suicidal thoughts. By the end of the year, the FDA required that all manufacturers of antiepileptic drugs include warnings of these tendencies on the drugs’ labels.
Specifically, the FDA added a “Suicidal Behavior and Ideation” entry to the “Warnings and Precautions” section of Lamictal’s label.
Lamictal and Stevens-Johnson Syndrome
About 10 percent of patients who take Lamictal experience a rash on some area of their bodies. Even though mostLamictal-induced rashes are not severe, if patients develop Stevens-Johnson Syndrome (SJS), they should immediately cease use of the drug.
SJS is a severe rash that can travel through all the mucous membranes in the body and is often life-threatening. Symptoms of SJS usually begin with a fever and sore throat, followed by blistering, lesions and ulcers in the mouth, on the lips and in the genital region.
Lamictal was first approved by the FDA in 1994 for use as adjunctive therapy in adults with partial seizures. The FDA added a black box warning for Lamictal in 1997, regarding the serious, life-threatening and sometimes fatal rashes reported in both adult and pediatric patients.
In September 2006, the FDA notified physicians and patients that babies who were exposed to Lamictal during the first trimester had a higher risk of being born with a cleft lip or cleft palate.
Lamictal-use has also been found to have a strong link to aseptic meningitis and suicidal thoughts.
If you or a loved one has taken Lamictal and suffered Stevens-Johnson Syndrome you may have cause to file aLamictal lawsuit. A dangerous drug lawyer at The Eichholz Law Firm will be able to guide you on the best course of legal action in pursuing compensation for your injuries.
For more information on the legal rights which may be available to Lamictal victims and their families, complete theFree Case Evaluation form on this page.